@article{UBHD-67834761,
  author={Hehlmann, R{\"u}diger and M{\"u}ller, Martin Christian and Hanfstein, Benjamin and Fabarius, Alice and Schreiber, Annette and Proetel, Ulrike and Dengler, Jolanta and Saußele, Susanne},
  title={Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib},
  subtitle={results from the randomized CML-study IV},
  year={2014},
  pages={415-423},
  language={eng},
  issn={1527-7755},
  volume={32},
  number={5},
  note={Gesehen am 23.06.2015},
  journal={Journal of clinical oncology},
  doi={10.1200/JCO.2013.49.9020},
}
@article{UBHD-68008069,
  author={Kalmanti, Lida and Saußele, Susanne and Proetel, Ulrike and M{\"u}ller, Martin Christian and Hanfstein, Benjamin and Schreiber, Annette and Fabarius, Alice and Dengler, Jolanta and Hehlmann, R{\"u}diger},
  title={Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators},
  subtitle={results from the randomized CML study IV},
  year={2014},
  pages={71-80},
  language={eng},
  issn={1432-0584},
  volume={93},
  number={1},
  note={Published online: 27 October 2013 ; Gesehen am: 15.07.2016},
  journal={Annals of hematology},
  doi={10.1007/s00277-013-1937-4},
}
@article{UBHD-67917006,
  author={Proetel, Ulrike and M{\"u}ller, Martin Christian and Hanfstein, Benjamin and Kalmanti, Lida and Schreiber, Annette and Hofmann, Wolf-Karsten and Hehlmann, R{\"u}diger and Saußele, Susanne},
  title={Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients},
  subtitle={a subanalysis of the randomized CML-Study IV},
  year={2014},
  pages={1167-1176},
  language={eng},
  issn={1432-0584},
  volume={93},
  number={7},
  note={Gesehen am: 16.12.2015},
  journal={Annals of hematology},
  doi={10.1007/s00277-014-2041-0},
}